Literature DB >> 16773355

Doxorubicin toxicity in the Iron Age.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16773355     DOI： 10.1007/s00109-006-0069-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  9 in total

1.  IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice.

Authors:  Gianfranca Corna; Bruno Galy; Matthias W Hentze; Gaetano Cairo
Journal:  J Mol Med (Berl)       Date:  2006-06-13       Impact factor: 4.599

2.  Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.

Authors:  G Minotti; R Ronchi; E Salvatorelli; P Menna; G Cairo
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

Review 3.  Molecular pharmacology of the interaction of anthracyclines with iron.

Authors:  X Xu; H L Persson; D R Richardson
Journal:  Mol Pharmacol       Date:  2005-05-09       Impact factor: 4.436

Review 4.  Molecular control of iron metabolism.

Authors:  Nancy C Andrews
Journal:  Best Pract Res Clin Haematol       Date:  2005-06       Impact factor: 3.020

5.  Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice.

Authors:  T LaVaute; S Smith; S Cooperman; K Iwai; W Land; E Meyron-Holtz; S K Drake; G Miller; M Abu-Asab; M Tsokos; R Switzer; A Grinberg; P Love; N Tresser; T A Rouault
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

Review 6.  Iron metabolism and the IRE/IRP regulatory system: an update.

Authors:  Kostas Pantopoulos
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 7.  Balancing acts: molecular control of mammalian iron metabolism.

Authors:  Matthias W Hentze; Martina U Muckenthaler; Nancy C Andrews
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

8.  Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.

Authors:  Esther G Meyron-Holtz; Manik C Ghosh; Kazuhiro Iwai; Timothy LaVaute; Xavier Brazzolotto; Urs V Berger; William Land; Hayden Ollivierre-Wilson; Alex Grinberg; Paul Love; Tracey A Rouault
Journal:  EMBO J       Date:  2004-01-15       Impact factor: 11.598

9.  New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.

Authors:  Ebtehal El-Demerdash; Azza A Ali; Mohamed M Sayed-Ahmed; Abdel-Moneim M Osman
Journal:  Cancer Chemother Pharmacol       Date:  2003-07-23       Impact factor: 3.333
  9 in total
  3 in total

Review 1.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

2.  Mechanisms of Anthracycline-Enhanced Reactive Oxygen Metabolism in Tumor Cells.

Authors:  James H Doroshow
Journal:  Oxid Med Cell Longev       Date:  2019-12-03       Impact factor: 6.543

3.  Effect of Anticancer Quinones on Reactive Oxygen Production by Adult Rat Heart Myocytes.

Authors:  James H Doroshow
Journal:  Oxid Med Cell Longev       Date:  2020-10-22       Impact factor: 6.543
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.